1260880-59-8 Usage
Uses
Used in Pharmaceutical and Chemical Research:
(3-amino-6-bromopyrazin-2-yl)methanol is used as a building block for the synthesis of various pharmaceuticals and fine chemicals. Its unique structure with a bromine atom, an amino group, and a hydroxyl group allows for versatile chemical modifications and incorporation into complex molecules.
Used in Medicinal Chemistry and Chemical Biology:
(3-amino-6-bromopyrazin-2-yl)methanol is used as a starting material for the development of new drugs and materials. Its potential biological activities make it a promising candidate for further research and exploration in the fields of medicinal chemistry and chemical biology.
Used in Drug Discovery and Development:
(3-amino-6-bromopyrazin-2-yl)methanol is used as a lead compound in drug discovery and development. Its unique chemical properties and potential biological activities can be harnessed to design and optimize new therapeutic agents with improved efficacy and selectivity.
Used in Chemical Synthesis:
(3-amino-6-bromopyrazin-2-yl)methanol is used as a reagent in various chemical synthesis processes. Its functional groups can participate in a wide range of chemical reactions, enabling the preparation of diverse chemical products and intermediates.
Check Digit Verification of cas no
The CAS Registry Mumber 1260880-59-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,8,8 and 0 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1260880-59:
(9*1)+(8*2)+(7*6)+(6*0)+(5*8)+(4*8)+(3*0)+(2*5)+(1*9)=158
158 % 10 = 8
So 1260880-59-8 is a valid CAS Registry Number.
1260880-59-8Relevant academic research and scientific papers
NEW ANTIBACTERIAL COMPOUNDS
-
Page/Page column 75, (2014/03/21)
The present invention is related to novel compounds of formula (I) that may inhibit the activity of the FabI enzyme, and which are useful in the treatment of bacterial infections. It further relates to pharmaceutical compositions comprising these compound
